A new study from Japan found that people with ANCA-associated vasculitis (AAV) have significantly higher levels of a protein known as AIM, fully apoptosis inhibitor of macrophage, in their urine than individuals without this vasculitis type — and these levels may be a useful way to monitor an individual’s…
Discussion
Those of us with ANCA vasculitis can find ourselves in the hospital for a variety of reasons. If you’re on Medicare, there is a little-known caveat related to hospitalizations that are coded as outpatient for observation. I learned this the hard way and want to be sure you know…
Discussion
Six-month remission rates with biosimilar versions of rituximab were similar to those seen with the original therapy among adults with the two most common types of ANCA-associated vasculitis (AAV), according to a real-world study in Canada. Data also showed no significant differences in serious adverse events or AAV-related…
Becoming educated and informed about ANCA vasculitis is a good first step. Here you’ll find general information such as the diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your ANCA vasculitis journey.
There is no cure for ANCA vasculitis yet, but here you can find more information about current approved treatments, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
